If confirmed as head of the Department of Health and Human Services, Kennedy could influence U.S. policy on vaccines, drugs and food safety.

Other drug manufacturers declined in the days following the nomination. Pfizer and Moderna have declined 6.9% and 6.2% ...

Putting enemies of science in charge of science policy is a formula for mass injury and death, history reminds us.

Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.

Robert F. Kennedy Jr.'s nonprofit, Children’s Health Defense, is involved in vaccine lawsuits against agencies he could wind ...

Experts warn of an expected winter COVID-19 surge, potentially impacting marginalized communities that have faced disproportionate effects since the pandemic began. Health advocates emphasize the need ...

If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to get vaccinated ahead of the holidays, when respiratory bugs tend to spread ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

Trump announced Thursday he'll nominate Robert F. Kennedy Jr. to be secretary of the Health and Human Services Department, ...

RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than did younger adults. Why? Boston Children's researchers, led by Byron Brook, ...

Shares of several COVID-19 vaccine developers sank fast enough to reflect investor jitters about vaccine policy given RFK’s ...